Alan S. Armstrong
Mr. Armstrong will continue to serve as President and Chief Executive Officer until July 1, 2025, at which point he will become Executive Chairman of the Board.
Highest-materiality recent filing
Williams Q1 net income $864M (+25% YoY); adj. EPS $0.73, record Adjusted EBITDA $2.254B
GAAP net income $864M ($0.70 EPS), up 25% vs Q1 2025; adjusted net income $895M ($0.73 EPS).
Alan S. Armstrong resigned as Executive Board Chair and director effective March 23, 2026, to accept appointment as U.S. Senator for Oklahoma.
GAAP net income $2.615B ($2.14 EPS), up 18% YoY; adjusted net income $2.571B ($2.10 EPS), up 9%.
Williams issues $2.75B in three-tranche senior notes offering
$500M 5.650% notes due 2033 (additional issuance), $1.25B 5.150% notes due 2036, $1B 5.950% notes due 2056.
Williams subsidiary Transco issues $1.7B senior notes in two tranches
Transco issued $1.0B of 5.100% Senior Notes due 2036 and $700M of 5.750% Senior Notes due 2056.
Williams Q3 adj. EPS $0.49 (+14% YoY), EBITDA $1.92B, reaffirms FY25 guidance, raises capex
GAAP net income $646M ($0.53 EPS); adjusted net income $603M ($0.49 adj. EPS), up 14% vs Q3 2024.
Williams invests $3.1B in two power projects; raises 2025 capex guidance
Invested ~$3.1B in two power innovation projects for grid-constrained markets, completion expected H1 2027.
Williams Q2 2025 Adj. EBITDA up 8% to $1.81B; raises FY guidance midpoint to $7.75B
GAAP net income $546M ($0.45 EPS); Adj. net income $566M ($0.46 EPS), up 7% YoY.
Williams prices $1.5B senior notes: $750M 4.625% '30 and $750M 5.300% '35
Issued $750M of 4.625% Senior Notes due 2030 at 99.920% of par.
Williams Q1 2025 beats: Adj. EPS $0.60, Adj. EBITDA $1.989B (+3% YoY), raises FY guidance to $7.7B
GAAP net income $690M ($0.56/diluted EPS), up 9% YoY; Adj. net income $730M ($0.60 Adj. EPS).
Williams (WMB) names Chad Zamarin CEO effective July 1; Armstrong becomes Executive Chairman
Chad Zamarin, EVP Corporate Strategic Development, succeeds Alan Armstrong as President and CEO effective July 1, 2025.
Williams to invest ~$1.6B in onsite power generation for large customer; raises capex guide
Investing ~$1.6B in committed power generation and gas pipeline infrastructure; completion expected H2 2026.
Williams 2024 record Adj. EBITDA $7.08B; raises 2025 guidance midpoint 3%
FY2024 Adj. EBITDA $7.08B (+4.4% YoY); Adj. EPS $1.92 (vs $1.91 YoY).
Williams issues $1.5B in senior notes: $1.0B at 5.600% due 2035, $500M at 6.000% due 2055
$1.0B of 5.600% Senior Notes due 2035 and $500M of 6.000% Senior Notes due 2055 issued on January 9, 2025.
Williams prices $1.5B senior notes in two tranches for debt repayment
$1.0B of 5.600% Senior Notes due 2035 priced at 99.843% of par.
Williams reports record Q3 Adjusted EBITDA $1.703B, raises FY2024 guidance midpoint
GAAP net income $705M ($0.58 EPS), up 8% YoY; adjusted net income $528M ($0.43 EPS).
Williams Q2 adj. EPS $0.43, adj. EBITDA $1.667B record; dividend +6.1% to $1.90
GAAP net income $401M ($0.33 EPS); adjusted net income $521M ($0.43 EPS).
Williams Q1 Adj. EBITDA up 8% to $1.934B; guides to top half of 2024 range
GAAP net income $631M ($0.52 EPS); adjusted net income $719M ($0.59 EPS), up 5% YoY.
Mr. Armstrong will continue to serve as President and Chief Executive Officer until July 1, 2025, at which point he will become Executive Chairman of the Board.
On May 5, 2025, The Williams Companies, Inc. (the “Company”) announced that Chad J. Zamarin has been named President and Chief Executive Officer of the Company and a member of the Board of Directors (the “Board”) of the Company, effective July 1, 2025, succeeding Alan S. Armstrong.
On April 24, 2025, The Williams Companies, Inc. (“the Company”) announced that Larry Larsen has been named Executive Vice President and Chief Operating Officer of the Company, effective May 3, 2025.
On March 13, 2025, Micheal G. Dunn, Executive Vice President and Chief Operating Officer indicated his intent to retire from The Williams Companies, Inc. (the “Company”) effective May 2, 2025.
Max materiality 0.85 · Median 0.65 · Most common event debt